Condition: Alopecia Areata · Alopecia Totalis · Alopecia Universalis · Sponsor: Erasmus Medical Center
A multicenter prospective registry (STA2R) is conducted to assess systemic treatments for alopecia areata, focusing on effectiveness, safety, and long-term outcomes.
This description comes directly from the study's public registry record.
DirkJan Hijnen, MD, PhD · 0031 10 704 01 10 · d.hijnen@erasmusmc.nl
Always discuss trial participation with your own doctor first.
| Erasmus University Medical Center | Rotterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06283316